Simplify Asset Management Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1846368
Las Vegas, NV
Position in NBIX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$558,710
+$228,702 QoQ
Shares Held
3,315
+32.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#460
of 768 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Simplify Asset Management Inc. holds $28,431,054 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (2.0% of the industry book) .
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,710 | 3,315 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $330,008 | 2,505 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $482,789 | 3,404 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,141,277 | 36,624 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $5,844,207 | 46,497 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,242,304 | 20,274 | Shares | Sole | 2025-05-13 | |
| 2024-06-30 | $3,143,556 | 22,834 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||